|
Pronunciation |
|
(nee
oh MYE sin & deks a METH a
sone) |
|
|
U.S. Brand
Names |
|
AK-Neo-Dex® Ophthalmic;
NeoDecadron® Ophthalmic; NeoDecadron® Topical;
Neo-Dexameth®
Ophthalmic |
|
|
Generic
Available |
|
No |
|
|
Synonyms |
|
Dexamethasone and Neomycin |
|
|
Pharmacological Index |
|
Antibiotic/Corticosteroid, Ophthalmic; Antibiotic/Corticosteroid,
Topical |
|
|
Use |
|
Treatment of steroid responsive inflammatory conditions of the palpebral and
bulbar conjunctiva, lid, cornea, and anterior segment of the
globe |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Adverse
Reactions |
|
<1%:
Ocular: Increased intraocular pressure, mydriasis, ptosis, epithelial
punctate keratitis, and possible corneal or scleral malacia can occur
|
|
|
Stability |
|
Store in tight, light-resistant container |
|
|
Usual Dosage |
|
Ophthalmic: Instill 1-2 drops in eye(s) every 3-4 hours
Topical: Apply thin coat 3-4 times/day until favorable response is observed,
then reduce dose to one application/day |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
See individual agents. Pregnancy/breast-feeding precautions: Inform
prescriber if you are or intend to get pregnant. Consult prescriber if
breast-feeding. |
|
|
Nursing
Implications |
|
May cause sensitivity to light, can minimize by wearing
sunglasses |
|
|
Dosage Forms |
|
Cream: Neomycin sulfate 0.5% [5 mg/g] and dexamethasone 0.1% [1 mg/g] (15 g,
30 g)
Ointment, ophthalmic: Neomycin sulfate 0.35% [3.5 mg/g] and dexamethasone
0.05% [0.5 mg/g] (3.5 g)
Solution, ophthalmic: Neomycin sulfate 0.35% [3.5 mg/mL] and dexamethasone
0.1% [1 mg/mL] (5 mL) |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|